Syneron Medical Ltd. (ELOS) is generally a thin volume stock, although it may see more active trading as the opening bell gets closer. Shares are indicated lower on an earnings warning. It sees $0.11 to $0.13 EPS and sees $29 to $30 million in revenues, while First Call estimates were $0.27 EPS and almost $35.8+ million in revenues. The company did not offer any reasoning in its release although you might easily surmise that cosmetic laser and light treatments for skin treatments must be more economically sensitive than razors. The company did want to convey its "value" by noting it has a cash position of $220 million with no debt, and that its shareholder equity is $255 to $256 million. Shares are indicated down about 12% at $9.96 early this morning, and that would be a new 52-week low under the $10.00 to $19.33 range over the last 52-weeks.
Jon C. Ogg
October 20, 2008